Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Champions Biotechnology
Of Mice and Men: Award-Winning Oncologist Leads New Advancement in Personalized Medicine
December 3rd, 2008
After hearing the words, "you've got cancer," most patients are given a drug or combination of agents according to guidelines or standards of care. These treatments, in the oncologist's best judgment, are considered most likely to work based on the results of clinical studies in patients with similar tumor types. Cancer patients often require several courses of drugs and regimens sequentially, that are ineffective or poorly tolerated, prior to identifying the optimal therapy. "In the meantime, precious time is lost, patients suffer unpleasant side effects, while tumors may continue to grow and mutate and become resistant to therapies, further reducing the future...
Source: Vaccine Weekly (2008-12-03)
|
